{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:16:07Z","timestamp":1791566167429,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U01HG007292"],"award-info":[{"award-number":["U01HG007292"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U24HG007307"],"award-info":[{"award-number":["U24HG007307"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["K08HG010488"],"award-info":[{"award-number":["K08HG010488"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10549-023-07007-w","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T08:02:24Z","timestamp":1689840144000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system"],"prefix":"10.1007","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-6298","authenticated-orcid":false,"given":"Sarah","family":"Knerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Wernli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen F.","family":"Mittendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Spencer","family":"Feigelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail P.","family":"Jarvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia L.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Keast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Liles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances L.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin R.","family":"Muessig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilyn M.","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wilfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina A. B.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"issue":"7","key":"7007_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","volume":"322","author":"DK Owens","year":"2019","unstructured":"Owens DK, Davidson KW, Krist AH et al (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA 322(7):652\u2013665","journal-title":"JAMA"},{"key":"7007_CR2","unstructured":"Genomics & Precision Health, Implementation Toolkit. https:\/\/www.cdc.gov\/genomics\/implementation\/toolkit\/tier1.htm"},{"key":"7007_CR3","unstructured":"National Comprehensive Cancer Network (2019) NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment: breast and Ovarian. Version 3.2019\u2013January 18, 2019. NCCN.org"},{"key":"7007_CR4","doi-asserted-by":"crossref","unstructured":"Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA (2018) Breast cancer screening in women at\u00a0higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3 Pt A):408\u2013414","DOI":"10.1016\/j.jacr.2017.11.034"},{"issue":"2","key":"7007_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2214\/AJR.19.22205","volume":"214","author":"CS Lee","year":"2020","unstructured":"Lee CS, Monticciolo DL, Moy L (2020) Screening guidelines update for average-risk and high-risk women. AJR Am J Roentgenol 214(2):316\u2013323","journal-title":"AJR Am J Roentgenol"},{"key":"7007_CR6","doi-asserted-by":"publisher","unstructured":"Warner E (2018) Screening BRCA1 and BRCA2 mutation carriers for breast cancer. Cancers (Basel) 10(12):477. 30 Nov 2018. https:\/\/doi.org\/10.3390\/cancers10120477","DOI":"10.3390\/cancers10120477"},{"issue":"4","key":"7007_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/jamainternmed.2017.8549","volume":"178","author":"DSM Buist","year":"2018","unstructured":"Buist DSM, Abraham L, Lee CI et al (2018) Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med 178(4):458\u2013468","journal-title":"JAMA Intern Med"},{"issue":"2","key":"7007_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10198-007-0042-9","volume":"8","author":"RP Norman","year":"2007","unstructured":"Norman RP, Evans DG, Easton DF, Young KC (2007) The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30\u201349. Eur J Health Econ 8(2):137\u2013144","journal-title":"Eur J Health Econ"},{"issue":"3","key":"7007_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10549-010-1043-4","volume":"125","author":"VR Grann","year":"2011","unstructured":"Grann VR, Patel PR, Jacobson JS et al (2011) Comparative effectiveness of screening and prevention strategies among BRCA1\/2-affected mutation carriers. Breast Cancer Res Treat 125(3):837\u2013847","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"7007_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427\u2013437","journal-title":"N Engl J Med"},{"issue":"9473","key":"7007_CR11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365(9473):1769\u20131778","journal-title":"Lancet"},{"issue":"5","key":"7007_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41436-020-0751-3","volume":"22","author":"L Petelin","year":"2020","unstructured":"Petelin L, Hossack L, Shanahan M et al (2020) Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers. Genet Med 22(5):831\u2013839","journal-title":"Genet Med"},{"issue":"8","key":"7007_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jval.2019.03.008","volume":"22","author":"L Petelin","year":"2019","unstructured":"Petelin L, Hossack L, Mitchell G, Liew D, Trainer AH, James PA (2019) A microsimulation model for evaluating the effectiveness of cancer risk management for BRCA pathogenic variant carriers: miBRovaCAre. Value Health 22(8):854\u2013862","journal-title":"Value Health"},{"issue":"20","key":"7007_CR14","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1002\/cncr.34429","volume":"128","author":"S Makhnoon","year":"2022","unstructured":"Makhnoon S, Chen M, Levin B et al (2022) Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes. Cancer 128(20):3709\u20133717","journal-title":"Cancer"},{"issue":"4","key":"7007_CR15","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1200\/OP.20.00262","volume":"17","author":"M Ter-Minassian","year":"2021","unstructured":"Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K (2021) Screening and preventative strategies for patients at high risk for breast cancer. JCO Oncol Pract 17(4):e575\u2013e581","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"7007_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10549-016-3748-5","volume":"156","author":"L Vetter","year":"2016","unstructured":"Vetter L, Keller M, Bruckner T et al (2016) Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany. Breast Cancer Res Treat 156(2):289\u2013299","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"7007_CR17","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1002\/cncr.33140","volume":"126","author":"KJ Wernli","year":"2020","unstructured":"Wernli KJ, Callaway KA, Henderson LM et al (2020) Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer 126(24):5293\u20135302","journal-title":"Cancer"},{"issue":"2","key":"7007_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"132","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L et al (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 132(2):428\u2013433","journal-title":"Gynecol Oncol"},{"key":"7007_CR19","doi-asserted-by":"crossref","unstructured":"Makhnoon S, Maki KG, Yu R, Peterson SK, Shete S (2022) Are beliefs about the importance of genetics for cancer prevention and early detection associated with high risk cancer genetic testing in the U.S. Population? Prev Med Rep 27:101781","DOI":"10.1016\/j.pmedr.2022.101781"},{"issue":"8","key":"7007_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1158\/1055-9965.EPI-20-0388","volume":"29","author":"J Chubak","year":"2020","unstructured":"Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB (2020) Methodologic considerations in calculating and analyzing proportion of time covered as a measure of longitudinal cancer screening adherence. Cancer Epidemiol Biomarkers Prev 29(8):1549\u20131556","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"7007_CR21","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10552-016-0808-4","volume":"27","author":"J Chubak","year":"2016","unstructured":"Chubak J, Ziebell R, Greenlee RT et al (2016) The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control 27(11):1315\u20131323","journal-title":"Cancer Causes Control"},{"issue":"1","key":"7007_CR22","first-page":"8","volume":"7","author":"S Sengupta","year":"2019","unstructured":"Sengupta S, Bachman D, Laws R et al (2019) Data quality assessment and multi-organizational reporting: tools to enhance network knowledge. EGEMS (Wash DC) 7(1):8","journal-title":"EGEMS (Wash DC)"},{"key":"7007_CR23","unstructured":"NCQA. Breast Cancer Screening (BCS, BCS-E). https:\/\/www.ncqa.org\/hedis\/measures\/breast-cancer-screening"},{"issue":"4","key":"7007_CR24","first-page":"A89","volume":"4","author":"KY Gregory-Mercado","year":"2007","unstructured":"Gregory-Mercado KY, Will J, True S et al (2007) A combined approach to women\u2019s health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women. Prev Chronic Dis 4(4):A89","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"7007_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0749-3797(98)00039-7","volume":"15","author":"L Song","year":"1998","unstructured":"Song L, Fletcher R (1998) Breast cancer rescreening in low-income women. Am J Prev Med 15(2):128\u2013133","journal-title":"Am J Prev Med"},{"issue":"5","key":"7007_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00124784-199809000-00010","volume":"4","author":"JL Evans","year":"1998","unstructured":"Evans JL, Nasca PC, Baptiste MS et al (1998) Factors associated with repeat mammography in a New York State public health screening program. J Public Health Manag Pract 4(5):63\u201371","journal-title":"J Public Health Manag Pract"},{"issue":"4","key":"7007_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1158\/1055-9965.620.13.4","volume":"13","author":"JK Bobo","year":"2004","unstructured":"Bobo JK, Shapiro JA, Schulman J, Wolters CL (2004) On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 13(4):620\u2013630","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"7007_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1148\/radiol.2541090953","volume":"254","author":"WA Berg","year":"2010","unstructured":"Berg WA, Blume JD, Adams AM et al (2010) Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 254(1):79\u201387","journal-title":"Radiology"},{"issue":"2","key":"7007_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jnci\/djab150","volume":"114","author":"IW Pan","year":"2022","unstructured":"Pan IW, Oeffinger KC, Shih YT (2022) Cost-sharing and out-of-pocket cost for women who received MRI for breast cancer screening. J Natl Cancer Inst 114(2):254\u2013262","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"7007_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jso.26761","volume":"125","author":"A Chichura","year":"2022","unstructured":"Chichura A, Hunt J, Lang J, Pederson H (2022) Lapses in breast cancer screening for highly penetrant mutation carriers during pregnancy and lactation. J Surg Oncol 125(4):589\u2013595","journal-title":"J Surg Oncol"},{"key":"7007_CR31","doi-asserted-by":"crossref","unstructured":"Mittendorf KF, Knerr S, Kauffman TL, et al (2021) Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities. JCO Precis Oncol 5","DOI":"10.1200\/PO.21.00233"},{"issue":"3","key":"7007_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10689-010-9333-x","volume":"9","author":"G Pichert","year":"2010","unstructured":"Pichert G, Jacobs C, Jacobs I et al (2010) Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1\/2 carriers. Fam Cancer 9(3):313\u2013319","journal-title":"Fam Cancer"},{"issue":"2","key":"7007_CR33","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1200\/OP.20.00256","volume":"17","author":"A Laws","year":"2021","unstructured":"Laws A, Mulvey TM (2021) Implementation of a high-risk breast clinic for comprehensive care of women with elevated breast cancer risk identified by risk assessment models in the community. JCO Oncol Pract 17(2):e217\u2013e225","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"7007_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10897-006-9052-5","volume":"15","author":"C Ricker","year":"2006","unstructured":"Ricker C, Lagos V, Feldman N et al (2006) If we build it \u2026 will they come?\u2013establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 15(6):505\u2013514","journal-title":"J Genet Couns"},{"issue":"2","key":"7007_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10897-018-0224-x","volume":"27","author":"SA Cohen","year":"2018","unstructured":"Cohen SA, Scherr CL, Nixon DM (2018) An iPhone application intervention to promote surveillance among women with a BRCA mutation: pre-intervention data. J Genet Couns 27(2):446\u2013456","journal-title":"J Genet Couns"},{"issue":"2","key":"7007_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.13966","volume":"100","author":"S Makhnoon","year":"2021","unstructured":"Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA (2021) Clinical management among individuals with variant of uncertain significance in hereditary cancer: a systematic review and meta-analysis. Clin Genet 100(2):119\u2013131","journal-title":"Clin Genet"},{"issue":"4","key":"7007_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaoncol.2021.6204","volume":"8","author":"KP Lowry","year":"2022","unstructured":"Lowry KP, Geuzinge HA, Stout NK et al (2022) breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: a comparative modeling analysis. JAMA Oncol 8(4):587\u2013596","journal-title":"JAMA Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07007-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T12:16:36Z","timestamp":1693138596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07007-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["7007"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07007-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest outside the grant funding listed in the funding section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Kaiser Permanente Northwest Institutional Review Board with a waiver of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}